Skip to main content
. 2021 Sep 15;4(9):e2125317. doi: 10.1001/jamanetworkopen.2021.25317

Table. Characteristics of Patients and Cancers Included in Primary Analysis.

Characteristic Patients, No. (%)
Patients, No. 269
Age, median (IQR), y 69 (62-75)
Sex
Male 217 (80.7)
Female 52 (19.3)
ECOG performance status
0 262 (97.4)
1 6 (2.2)
2 1 (0.4)
Tumor location
Upper thoracic esophagus 41 (15.2)
Middle thoracic esophagus 153 (56.9)
Lower thoracic esophagus 75 (27.9)
Macroscopic typea
0-I 11 (4.1)
0-IIa 22 (8.2)
0-IIb 6 (2.2)
0-IIc 121 (45.0)
Mixed
Including 0-I 42 (15.6)
Not including 0-I 67 (24.9)
Tumor diameter, median (IQR), cm 2.0 (1.5-3.0)
Tumor circumference
<1/4 95 (35.3)
≥1/4 to <1/2 95 (35.3)
≥1/2 to <3/4 56 (20.8)
≥3/4 23 (8.6)
Procedure time of non-ME and ME, median (IQR), min 8 (6-11)
Diagnoses by non-ME and ME
Clinical MM/SM1 195 (72.5)
Clinical SM2 74 (27.5)
Procedure time of EUS, median (IQR), min 9 (6-13)
Scanning method of EUS
Water–filling 131 (48.7)
Jelly–filling 118 (43.9)
Water–filled balloon 20 (7.4)
Diagnoses by non-ME and ME plus EUS
Clinical EP/LPM 22 (8.2)
Clinical MM/SM1 144 (53.5)
≤Clinical SM2 103 (38.3)
Confidence level of EUS diagnoses
Low 109 (40.5)
High 160 (59.5)
Resection
Endoscopic 200 (74.3)
Surgical 69 (25.7)

Abbreviations: ECOG, Eastern Cooperative Oncology Group; EP, epithelium; EUS, endoscopic ultrasonography; IQR, interquartile range; LPM, lamina propria; ME, magnifying endoscopy; MM, muscularis mucosa; non–ME, nonmagnifying endoscopy; SM, submucosa.

a

Type 0-I indicates protruded lesion; type 0-IIa, superficial and elevated lesion; type 0-IIb, flat lesion; and type 0-IIIc, superficial and depressed lesion.